Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

PF-06305591

Generic Name: PF-06305591

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₂₂N_₄O

CAS Number: 1449473-97-5

Unique Ingredient Identifier: G5Y3F1X9MU

Overview

Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple Doses of PF-06305591).

Background

Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple Doses of PF-06305591).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Mechanism of Human Cold Pain Perception - Involvement of TRPA1, TRPM8, Nav1.7 and Nav1.8

Early Phase 1

Completed

Posted: 2023/07/07

Sponsor:Medical University o...

ID:NCT05935280

Cold Pressor Test is Used in This Study to Assess the Effect of PF-06305591 on Pain Intensity Evoked by Cold in Healthy Male Subjects

Phase 1

Completed

Posted: 2013/03/18

Sponsor:Pfizer

ID:NCT01812265

Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare

Phase 1

Completed

Posted: 2013/02/25

Sponsor:Pfizer

ID:NCT01797796

Safety and Tolerability Study of Multiple Doses of PF-06305591

Phase 1

Completed

Posted: 2013/01/28

Sponsor:Pfizer

ID:NCT01776619

Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects

Phase 1

Completed

Posted: 2012/12/12

Sponsor:Pfizer

ID:NCT01747941

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy